Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Vaccine Efficacy
50%
Arm
50%
Antibody Response
50%
Glycoprotein
50%
Rift Valley Fever Virus
50%
Normal Human
50%
Immunogenicity
50%
Lamb
33%
COVID-19
31%
Probiotic
25%
Neutralizing Antibody
22%
Nucleic Acid Amplification
16%
Viral Load
16%
Laboratory Test
16%
Zoonotic
16%
Subunit Vaccine
16%
Mouse Model
16%
Viremia
16%
Conformation
16%
Geobacillus stearothermophilus
16%
Receptor Binding
12%
Immunoglobulin A
12%
Antibody Titer
12%
Spike
6%
Blood Level
6%
Antibody Blood Level
6%
Colony-Forming Unit
6%
Medicine and Dentistry
Arm
50%
Supplementation
50%
Placebo
50%
Antibody Response
50%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Probiotics
25%
Infection
12%
Receptor Binding
12%
COVID-19 Vaccine
12%
COVID-19 Vaccination
12%
Colecalciferol
12%
Immunoglobulin A
12%
Messenger RNA
12%
Intervention Study
6%
Student T Test
6%
Respiratory Tract Infection
6%
Intention-to-Treat Analysis
6%
Neutralizing Antibody
6%
COVID-19
6%
Biochemistry, Genetics and Molecular Biology
Rift Valley Fever Virus
50%
Glycoprotein
50%
Scaffold Protein
50%
Immunogenicity
30%
Lamb
20%
Synthase
10%
Aldolase
10%
Genetics
10%
Mouse Model
10%
Conformation
10%
Geobacillus stearothermophilus
10%
Viremia
10%
Neutralizing Antibody
10%
Fructose-Bisphosphate Aldolase
10%